Genomics, Inc. , a leader in single cell and spatial biology, today announced Atera, a new in situ spatial biology platform engineered to deliver whole-transcriptome spatial analysis with single-cell ...
Bruker Corporation (Nasdaq: BRKR) today announced new updates from Bruker Spatial Biology to be showcased at the 2026 ...
One in five people worldwide suffers from chronic inflammatory pain. Meanwhile, about two thirds of those affected find ...
Spatial biology is a rapidly advancing discipline that examines biological molecules (such as DNA, RNA, and proteins) within their native locations in tissues. This approach offers critical insight ...
Abstract: Single-cell spatial multi-omics sequencing technology can simultaneously obtain multiple omics data, such as transcriptome and epigenome, along with their spatial location information, ...
SAN DIEGO, Feb. 25, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced new customer breakthroughs in oncology powered by Illumina's spatial transcriptomics, 5-base sequencing, and ...
ORLANDO, Fla.--(BUSINESS WIRE)--$BRKR #BRKR--Bruker Spatial Biology, a division of Bruker Corporation (Nasdaq: BRKR) announced today that it will expand its ...
Bruker Corporation (Nasdaq: BRKR) announced today significant portfolio advancements from Bruker Spatial Biology to be unveiled at the 2026 Advances in Genome Biology and Technology (AGBT) General ...
Portfolio innovations include the launch of the new CellScape XR spatial proteomics platform, the unique CosMx mouse whole transcriptome panel, the launch of the PaintScape platform for 3D genome ...
Background: Moyamoya disease (MMD) is a rare progressive cerebrovascular disease that can lead to ischemic and hemorrhagic strokes. The pathology of MMD arteries includes thickening of the innermost ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results